Evidence obtained in myeloid cells expressing or not the PML-RARα and in RA-resistant myeloid cells lines suggested that RA-induced reformation of PML-NBs and oncoprotein degradation, two events contributing to the therapeutic effect of RA in APL, is tightly correlated with the restoration of DDR in APL cells. This evidence concerns the gene PML and acute promyelocytic leukemia.